Unlike melanoma and lung cancer, PCa has low levels of infiltrating CD8+ T cells, high proportion of MDSCs and tumour promoting M2 macrophages, therefore ICI are unlikely to work in majority of PCa patients [36,37]. This evidence concerns the gene CD8A and lung carcinoma.